Lilly Breast Cancer Treatment Lands Another Approval

Posted: Updated:

The U.S. Food and Drug Administration has given another approval for a breast cancer treatment developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The announcement marks the third FDA approval for Verzenio in five months.

The most recent ruling approves Verzenio, also known as abemaciclib, for use in combination with an aromatase inhibitor as an initial endocrine-based therapy for the treatment of postmenopausal women with advanced or metastatic breast cancer. Lilly says the approval follows the results of a successful Phase 3 clinical trial.

"This approval is an important milestone, as it shows that Verzenio plus an aromatase inhibitor substantially reduced tumor size and delayed disease progression in women with HR+, HER2- metastatic breast cancer," said Joyce O'Shaughnessy, chair of the Breast Cancer Research Program at Baylor University Medical Center in Texas. "This information will help inform treatment decisions for each patient, which can be complicated in advanced breast cancer."

In September the FDA also approved Verzenio for use among women with advanced or metastatic breast cancer in combination with an endocrine therapy called fulvestrant, as well as on its own in patients who previously received endocrine therapy and chemotherapy after the cancer had spread.

You can learn more about the approval and the Phase 3 study involved by clicking here.

  • Perspectives

    • Indiana Isn't 'Silicon Prairie,' It's The Nation's Nucleus

      Dear Career Seekers and Job Creators: Several years ago, I was lying in bed thinking about the incredible transformation that has occurred in Indiana over the last 20 years and the phrase "The Nation's Nucleus" popped into my head. Indiana has been called the Silicon Prairie and the "Crossroads of America," but the ingredients to be The Nation's Nucleus go much deeper.



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • (photo courtesy Cook Group)

      Cook to Begin Work on GE Plant Renovations

      Bloomington-based Cook Group will Friday break ground on its newest facility, located on the site of the former GE refrigeration plant on the city’s west side. The company acquired the site in November and said the development would lead to 500 new jobs over the next 10 years. 

    • Developers Show Interest in 'North River' Site

      A 29-acre site that formerly housed a metal recycling facility in Fort Wayne has garnered interest from potential developers. Our partners at WPTA-TV report IU Health is among four groups that have submitted qualifications for the North River property. 

    • Surgeon General Talks Indiana Opioid Crisis

      U.S. Surgeon General Jerome Adams, who served three years as Indiana's state health commissioner, says better partnerships are key to putting a dent in the opioid crisis statewide and throughout the country. In an interview with Inside INdiana Business, Adams said the combination of more federal dollars and a focus at all levels of government on "better health through better partnerships" is a good start toward getting a handle on the issue.

    • (photo courtesy Purdue University)

      Purdue Dedicates Animal Sciences Complex

      Purdue University is celebrating the dedication of its $60 million animal sciences complex. The 123,000-square-foot complex includes two buildings that feature research laboratories, classrooms, and interactive spaces. Purdue says the facility boosts its "commitment to Indiana’s vital food animal production industry by establishing a center for interactive student learning, advanced research and enhanced Extension programming." 

    • Indy Library to Break Ground on New Branch

      The Indianapolis Public Library will Friday break ground on the new $8 million Eagle Branch. The library says the project is part of its long-range strategic plan to boost access to services and improve visibility on Indy’s west side.